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INTRODUCTION
Inhibition of target of rapamycin complex 1 (TORC1) with rapamycin or its analogs has increasingly been put forward as an attractive treatment for a number of disorders, including genetic syndromes such as Tuberous Sclerosis Complex (TSC), Neurofibromatosis type I (NFI) and Phosphatase and Tensin homologue (PTEN)-tumor hamartoma syndromes (1), sporadic cancers (2), epilepsy (3) , and aging-related disorders (4) . Long-term treatment is currently being considered for individuals with TSC, for whom it might also be advantageous to start treatment early in life (5, 6) .
However, it is not yet clear how sustained suppression of TORC1 activity affects brain development and/or cognitive function.
In the brain, TORC1 is important for long-term memory formation and its cellular correlate, the late (protein synthesis dependent) phase of long-term potentiation (L-LTP) (elegantly reviewed in (7)). This is accomplished by phosphorylation of its downstream targets that include p70 S6 kinase (S6K) and the eukaryotic initiation factor 4E (eIF4E)-binding proteins 1 and 2 (4E-BP1 and 4E-BP2) (7) . Hence, long-term treatment with TORC1 inhibitors could potentially lead to serious cognitive side effects, but so far no conclusive clinical data addressing this concern is available. Moreover, even in animal studies the consequences of TORC1 hypo-activity on neuronal function are not fully understood. As shown in supplementary tables 1 and 2, in which we summarized the available studies focusing on the effect of TORC1 down-regulation by rapamycin on learning and memory, the effect of rapamycin is highly dependent on dose and administration time-point. For instance, acute treatment with rapamycin blocked L-LTP in vitro (8, 9) but not in vivo (10) , and systemic administration of a high dose of rapamycin impaired learning and memory formation in some studies (11, 12) , but not in others (13, 14) . Genetic by guest on http://hmg.oxfordjournals.org/ Downloaded from 4 approaches are ideally suited to study the effect of prolonged TORC1 hypo-activity, in a controlled way, but also these studies have not been conclusive. Heterozygous
Tor knock-out mutants showed no decrease of phosphorylated S6K1 (pS6K1) in the brain nor any changes in L-LTP. (14) . Administration of a sub-threshold dose of rapamycin to these animals reduced pS6K1 activation by 50% after high-frequency stimulation (HFS) and resulted in impaired L-LTP and memory (14) . In contrast, S6k1/2 knockout mice show normal L-LTP and only subtle alterations in learning (15) . However, in the latter mutants it cannot be ruled out that other TORC1 targets are more critical for these processes. Here we made use of the observation that the amount of RHEB1 (RAS homolog enriched in brain) is rate-limiting for TORC1 activation (16) . Hence we used Rheb1 mutants to investigate the consequences of long-term TORC1 hypo-activity (during and after brain development) on plasticity and learning.
RESULTS

Plasticity and learning is intact in Rheb1
+/-mice despite a significant reduction in TORC1 activity.
Whereas modest increases in TORC1 activity already result in learning deficits in human and mice (1, 13, 17) , the effect of decreased TORC1 signaling is less clear.
We summarized the available studies focusing on the effect of TORC1 downregulation by rapamycin on learning and synaptic plasticity (Supplementary Tables 1   and 2 ). From this overview it appears that the effect of rapamycin is highly dependent on dose and time of administration. Hence, we decided to use a genetic approach to investigate the effect of sustained TORC1 hypo-activity on neuronal function by Fig. 1E ).
Water maze learning and contextual fear conditioning are both sensitive to hippocampal dysfunction and have also been shown to be sensitive to changes in TORC1 activity (1, (11) (12) (13) (14) 17 trained on day 13 and tested on day 14 after initiation of Rheb1 deletion respectively (t 1,13 = 0.22; p = 0.83, unpaired t-test; Fig. 3E ). Hence, despite a marked reduction in TORC1 activity in these mice, no effect was observed on L-LTP and learning.
Acute loss of Rheb1 in excitatory forebrain neurons cells does not affect hippocampal dependent learning and memory.
Because ;Camk2-Cre ERT2 mutants showed normal survival, appeared healthy and showed no deficits in a locomotion task (Suppl. Fig. 3B ). We confirmed the specific deletion of Rheb1 in the hippocampus, cortex and striatum by performing immunohistochemistry using a RHEB1 antibody (Fig. 4A) . To quantify the loss of the protein and to assess the affect on TORC1 activity we performed Western-blot analysis of the hippocampus (Fig 4B and Suppl. Fig 3A) . We observed 80% reduction of RHEB1 protein and 74% reduction of phosphorylation of S6 (S240/244) relative to wild-type mice.
After having established that these mice have a severe reduction in Rheb1-TORC1 signalling, we tested the ability to learn the water maze in these mice. We observed no significant difference in their performance during training (F 1,28 = 3.02; p = 0.09, two-way repeated-measures ANOVA; Fig. 4C ) nor at the probe trial given after 7 days of training (F 3,112 = 1.97; p=0.12, two-way ANOVA genotype x quadrant interaction; Fig. 4D ). We also did not observe a significant deficit in the long-term memory/memory retrieval tested 14 days after the last training (F 3,120 = 2. although to a lesser extent (22) . Little is known about its function in vivo, however,
given the profound reduction of pS6 levels in our Rheb1 mutant mice, RHEB1 seems to be the most important regulator of TORC1 activity in the brain.
Remarkably, despite the marked and sustained reduction in TORC1 activity, all three mutants showed intact synaptic plasticity and learning. Hence, our data provides further support of the notion that TORC1-dependent regulation of LTP and learning is much more sensitive to up-than down-regulation, as modest increases in TORC1 activity already result in learning deficits in human and mice (1, 13, 17).
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Our results contradict several reports studying acute, pharmacological TORC1
inhibition by rapamycin (reviewed in (7) and see Supplementary Table 1) . However, it is important to note that there are also inconsistencies in the outcome of these studies. Notably, very high concentrations of rapamycin (for example 140 mg/kg) (13) or the administration at a certain time-point during the experiment (e.g. immediately after fear memory consolidation (23) or during the induction phase of L-LTP (9)) were required to impair learning and plasticity in mice (see Supplementary Table 1 and 2).
In contrast, studies that used chronic treatment with rapamycin for several weeks even showed an improvement of learning and memory in aging as well as in young mice (24) (25) (26) . Also in line with these results is, that in Tor +/-mice long-term memory and L-LTP was only impaired after TORC1 activity was acutely pharmacologically further down regulated by rapamycin administration, whereas the genetic down-regulation of TORC1 activity by itself showed no effect (14) . This could be explained by the observation of Garelick et al. that acute rapamycin treatment leads to a reduction of ribosome activity, whereas chronic treatment does not show an effect on overall translation (27) . Hence, protein translation necessary for memory formation could be sensitive to a single rapamycin dose, but compensatory mechanisms appear to be in place upon long-term rapamycin treatment. These results
show that there is a difference between chronic vs. acute TORC1 down-regulation.
A study by Tsai et al. (28) showed that a single dose of 1 mg/kg at E16.5 in pregnant dams leads to late and early behavioural deficits in wild-type mice, but this study did not assess learning and memory or changes in synaptic plasticity in these mice. Our study, on the other hand, shows that early, sustained inhibition of TORC1 
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MATERIALS AND METHODS
Mice
Mice carrying a floxed Rheb1 allele or a heterozygous Rheb1 knock-out allele (19) were crossed at least 12 times into the C57BL/6JOlaHsd background. Protein-bands were visualized using Enhanced Chemo Luminescence (Pierce; Thermo
Fisher Scientific, Waltham, MA) and quantified using ImageJ64 software. All samples were run in at least two independent experiments.
Immunohistochemistry
Mice were perfused with 4% paraformaldehyde, brains were dissected and embedded 
Hippocampal field recordings
Extracellular recordings of fEPSPs in CA1 striatum radiatum were performed as described (36) . For 100 Hz stimulation protocols, stimulation was performed at 1/3 of the maximum response during the LTP experiment and at 2/3 of the maximum response for the theta-burst experiment. Test stimulations were given once a minute during early LTP (E-LTP) experiments, and once every five minutes during L-LTP experiments. For statistical analyses N=number of slices.
Morris water maze
Before starting the Morris water maze, mice were handled daily for a week. The pool measures 1.2 m in diameter and contains an 11 cm diameter platform submerged 1 cm below the surface of the water (26°C) that was painted milk-white. We used dimmed lighting and SMART version 2.0 (Panlab, Barcelona, Spain) to track the mice. Mice were given 2 trials per day, with a 30-second intertrial interval for 9 consecutive days.
At a training session, the mouse was first placed on the platform for 30 seconds, then placed in the water at a pseudorandom start position and given a maximum of 60 seconds to find the platform. If the mouse did not find the platform within 60 seconds, it was placed back on the platform. After 30 seconds on the platform, this procedure was repeated once more. The platform position remained the same during all trials. A probe trial in which no platform was present was given on the days indicated in the text and figure legends. In this test, mice were placed at the opposite side of the previous platform position and were allowed to search for the platform for 60 seconds. For long-term memory testing, a probe trial was given 14 days after the last training.
Contextual Fear Conditioning
Fear conditioning was performed in a conditioning chamber (Med Associates Inc., St.
Albans, VT) equipped with a grid floor via which the foot shock could be by guest on http://hmg.oxfordjournals.org/ Downloaded from 16 administered. Each mouse was placed inside the conditioning chamber for 180 seconds. A foot shock (2 seconds, 0.6 mA) was delivered 148 seconds after placement in the chamber. Twenty-four hours later, context-dependent freezing was measured during 3 minutes. For long-term memory testing, the context-dependent freezing was tested 7 and 22 days after the initial training.
Rotarod
To test motor behavior, mice were trained on the accelerated rotarod for 4 consecutive days. On the first day they had 5 trials and the following three days 2 trials a day with a constant inter trial time of 1 h. The accelerated rotarod reaches its maximum speed of 40 rpm after four minutes and 30 seconds. After a total of 5 minutes the rotarod was stopped. For each mouse the time that they were capable to keep running was noted.
PCR analysis
For genotyping the following primers were used: Forward (F): 5'-AGTGTTCTCCACAGAGC-3', Reverse (R): 5'-ACAGGGACAGATTCAGTC-3'
and R: 5'-CCGCTGTGTCTACAAGC-3', yielding a 360 bp product from the wildtype allele, a 500 bp product from the floxed allele and a 209 bp product from the knock-out allele. PCR analysis was performed on hippocampal tissue.
Statistical analysis
GraphPad Prism data analysis software (San Diego, CA) was used for graph production and statistical analysis. 
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